Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease
Clinical trial NCT05161715 · COMPLETED
Trial details
- NCT number
- NCT05161715
- Sponsor
- NewAmsterdam Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-12
- Primary completion
- 2023-05-09
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.